Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma

被引:0
|
作者
M Santoni
U De Giorgi
R Iacovelli
A Conti
L Burattini
L Rossi
S Luca Burgio
R Berardi
G Muzzonigro
E Cortesi
D Amadori
S Cascinu
机构
[1] Clinica di Oncologia Medica,Dipartimento di Scienze Radiologiche
[2] AOU ‘Ospedali Riuniti’,Dipartimento di Scienze Cliniche Specialistiche ed Odontostomatologiche
[3] Università Politecnica delle Marche,undefined
[4] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-IRST,undefined
[5] Oncologiche e Anatomo-Patologiche,undefined
[6] ‘Sapienza’ Università di Roma,undefined
[7] Clinica di Urologia,undefined
[8] AOU ‘Ospedali Riuniti’,undefined
[9] Università Politecnica delle Marche,undefined
来源
British Journal of Cancer | 2013年 / 109卷
关键词
renal cell carcinoma; mTOR inhibitors; tyrosine kinase inhibitor; targeted therapy; everolimus; neutrophil-to-lymphocyte ratio;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1755 / 1759
页数:4
相关论文
共 50 条
  • [1] Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
    Santoni, M.
    De Giorgi, U.
    Iacovelli, R.
    Conti, A.
    Burattini, L.
    Rossi, L.
    Burgio, S. Luca
    Berardi, R.
    Muzzonigro, G.
    Cortesi, E.
    Amadori, D.
    Cascinu, S.
    BRITISH JOURNAL OF CANCER, 2013, 109 (07) : 1755 - 1759
  • [2] The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma
    Parosanu, Andreea Ioana
    Pirlog, Cristina Florina
    Slavu, Cristina Orlov
    Stanciu, Ioana Miruna
    Cotan, Horia-Teodor
    Vrabie, Radu Constantin
    Popa, Ana-Maria
    Olaru, Mihaela
    Iaciu, Cristian
    Bratu, Lucian Ioan
    Baicoianu, Ionut Florian
    Moldoveanu, Oana
    Baston, Catalin
    Nitipir, Cornelia
    CURRENT ONCOLOGY, 2023, 30 (02) : 2457 - 2464
  • [3] Emphasis of neutrophil-to-lymphocyte ratio in non-metastatic renal cell carcinoma
    Ceylan, Cavit
    Camtosun, Ahmet
    Doluoglu, Omer Gokhan
    Tasdemir, Sedat
    Keles, Ibrahim
    Aglamis, Erdogan
    Tatar, Can Ali
    UROLOGIA JOURNAL, 2014, 81 (01) : 51 - 56
  • [4] Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy
    Zeng, Yue-Can
    Chi, Feng
    Xing, Rui
    Xue, Ming
    Wu, Li-Na
    Tang, Mei-Yue
    Wu, Rong
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (02) : 126 - 131
  • [5] Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy
    Zhang, Gui-Ming
    Zhu, Yao
    Gu, Wei-Jie
    Zhang, Hai-Liang
    Shi, Guo-Hai
    Ye, Ding-Wei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) : 373 - 378
  • [6] Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy
    Gui-Ming Zhang
    Yao Zhu
    Wei-Jie Gu
    Hai-Liang Zhang
    Guo-Hai Shi
    Ding-Wei Ye
    International Journal of Clinical Oncology, 2016, 21 : 373 - 378
  • [7] Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma
    Day, D.
    Kanjanapan, Y.
    Kwan, E.
    Yip, D.
    Lawrentschuk, N.
    Davis, I. D.
    Azad, A. A.
    Wong, S.
    Rosenthal, M.
    Gibbs, P.
    Tran, B.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (11) : 1291 - 1297
  • [8] Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy
    Templeton, Arnoud J.
    Knox, Jennifer J.
    Lin, Xun
    Simantov, Ronit
    Xie, Wanling
    Lawrence, Nicola
    Broom, Reuben
    Fay, Andre P.
    Rini, Brian
    Donskov, Frede
    Bjarnason, Georg A.
    Smoragiewicz, Martin
    Kollmannsberger, Christian
    Kanesvaran, Ravindran
    Alimohamed, Nimira
    Hermanns, Thomas
    Wells, J. Connor
    Amir, Eitan
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY, 2016, 70 (02) : 358 - 364
  • [9] Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer
    Minardi, Daniele
    Scartozzi, M.
    Montesi, L.
    Santoni, M.
    Burattini, L.
    Bianconi, M.
    Lacetera, V.
    Milanese, G.
    Cascinu, S.
    Muzzonigro, G.
    SPRINGERPLUS, 2015, 4
  • [10] The Prognostic Role of Pre-Treatment Neutrophil-to-Lymphocyte Ratio in an Asian Cohort of Patients with Oropharyngeal Squamous Cell Carcinoma
    Jang, Isabelle J. H.
    Kadir, Hanis B. Abdul
    Lim, Kok Hing
    Chew, Wen Chao Daniel
    Hwang, Jacqueline S. G.
    Lim, Chwee Ming
    CURRENT ONCOLOGY, 2024, 31 (11) : 7074 - 7087